Molecular and cellular mechanisms of action of angiotensin II (AT1) receptors in vascular smooth muscle

Journal of Human Hypertension

Volumn 12, Issue 5, 1998, Pages 275-281

  Hughes, A D ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Angiotensin II; Ion channels; Signal transduction; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; CALCIUM ION; ION CHANNEL; PHOSPHOLIPASE C; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

CALCIUM CELL LEVEL; CONFERENCE PAPER; RECEPTOR BINDING; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0031800636     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000635     Document Type: Conference Paper

References (99)

1. Editorial. Angiotensin II: Hemodynamic regulator or growth factor? J Mol Cell Cardiol 1995; 22: 739-747.
2. Unger T et al. Angiotensin receptors. J Hypertens 1996; 14 (Suppl): S95-S103.
3. Timmermans PBWM et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45: 205-251.
4. Neer EJ. G proteins: critical control points for transmembrane signals. Protein Sci 1994; 3: 3-14.
5. Duff JL et al. Angiotensin II signal transduction and the mitogen-activated protein kinase pathway. Cardiovasc Res 1995; 30: 511-517.
6. Griendling KK, Lassegue B, Alexander RW. Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol 1996; 36: 281-306.
7. Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circ Res 1997; 80: 607-616.
8. Schlessinger J, Ullrich A. Growth factor signalling by receptor tyrosine kinases. Neuron 1992; 9: 383-391.
9. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Ann Rev Cell Dev Biol 1995; 11: 549-599.
10. Benton HP. Cytokines and their receptors. Curr Opin Cell Biol 1991; 3: 171-175.
11. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle [published erratum appears in Nature, 1994, Dec 22-29; 372(6508): 812]. Nature 1994; 372: 231-236.
12. Stull JT, Gallagher PJ, Herring BP, Kramm KE. Vascular smooth muscle contractile elements. Cellular regulation. Hypertension 1991; 17: 723-732.
13. Kureishi Y et al. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 1997; 272: 12257-12260.
14. Horowitz A, Menice CB, Laporte R, Morgan KG. Mechanisms of smooth muscle contraction. Physiol Rev 1996; 76: 967-1003.
15. Henrion D, Laher I, Laporte R, Bevan JA. Further evidence from an elastic artery that angiotensin II amplifies noradrenaline-induced contraction through activation of protein kinase C. Eur J Pharmacol 1992; 224: 13-20.
16. ++ influx: role of protein kinase C. J Pharmacol Exp Ther 1992; 261: 835-840.
17. Oike M, Takahashi N, Ito Y. Angiotensin II attenuates vascular contractililty in the rabbit mesenteric artery. Biochem Biophys Res Commun 1996; 222: 208-214.
18. Ashida T et al. Role of sarcoplasmic reticulum in arterial contraction. Comparison of ryanodines effect in a conduit and a muscular artery. Circ Res 1988; 62: 854-863.
19. Garcha RS, Hughes AD. Inhibition of norepinephrine and caffeine-induced activation by ryanodine and thapsigargin in rat mesenteric arteries. J Cardiovasc Pharmacol 1995; 25: 840-846.
20. Cai G, Gurdal H, Seasholtz TM, Johnson MD. Age-related changes in angiotensin II-stimulated vascular contraction and inositol phosphate accumulation in Fischer 344 rats. Mech Ageing Dev 1994; 76: 125-133.
21. Ohanian J, Izzard A, Littlewood M, Heagerty A. Regulation of diacylglycerol metabolism by vasoconstrictor hormones in intact small arteries. Circ Res 1993; 72: 1163-1171.
22. Boyer JL, Hepler JR, Harden TK. Hormone and growth factor receptor-mediated regulation of phospholipase C activity. Trends Pharmacol Sci 1989; 10: 360-364.
23. Homma Y et al. Evidence for involvement of phospholipase C-gamma 2 in signal transduction of platelet-derived growth factor in vascular smooth-muscle cells. Biochem J 1993; 290: 649-653.
24. Marrero MB et al. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-gamma 1 in vascular smooth muscle cells. J Biol Chem 1994; 269: 10935-10939.
25. Smith EB. Fibrinogen, fibrin and the arterial wall. Eur Heart J 1995; 16 (Suppl A): 11-14.
26. 2+ from intracellular stores in rat portal vein myocytes. Br J Pharmacol 1996; 118: 73-78.
27. 2+ channel. FEBS Lett 1995; 377: 159-162.
28. Wilkinson SE, Hallam TJ. Protein kinase C: is its pivotal role in cellular activation over-stated. Trends Pharmacol Sci 1994; 15: 53-57.
29. Ohanian V et al. Identification of protein kinase C isoforms in rat mesenteric small arteries and their possible role in agonist-induced contraction. Circ Res 1996; 78: 806-812.
30. Rao GN, Lassegue B, Alexander RW, Griendling KK. Angiotensin II stimulates phosphorylation of high-molecular-mass cytosolic phospholipase A2 in vascular smooth-muscle cells. Biochem J 1994; 299: 197-201.
31. Stern N et al. Selective inhibition of angiotensin II-mediated vasoconstriction by lipoxygenase blockade. Am J Physiol 1989; 257: 434-443.
32. Hollenberg MD. Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci 1994; 15: 108-114.
33. Clement CO, Walsh MP, Cole WC. Angiotensin II activation of protein kinase C decreases delayed rectifier K+ current in rabbit vascular myocytes. J Physiol Lond 1996; 495: 689-700.
34. Wijetunge S, Aalkjaer C, Schachter M, Hughes AD. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun 1992; 189: 1620-1623.
35. Wijetunge S, Hughes AD. pp60src increases voltage-operated calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun 1995; 217: 1039-1044.
36. Wijetunge S, Hughes AD. Effect of platelet-derived growth factor on voltage-operated calcium channels in isolated rabbit ear artery cells. Br J Pharmacol 1995; 115: 534-538.
37. Toma C, et al. Effects of tyrosine kinase inhibitors on the contractility of rat mesenteric resistance arteries. Br J Pharmacol 1995; 114: 1266-1272.
38. Di SJ, Nelson SR, Kaplan N. Protein tyrosine phosphorylation in smooth muscle: a potential coupling mechanism between receptor activation and intracellular calcium. Proc Soc Exp Biol Med 1997; 214: 285-301.
39. Malloy LG, Sauro MD. Tyrosine kinase inhibition suppresses angiotensin contraction in hypertensive and normotensive small resistance arteries. Life Sci 1996; 58: L317-L324.
40. i) transients in vascular smooth muscle cells. Hypertension 1996; 27: 1097-1103.
41. Laniyonu AA, Saifeddine M, Yang S-G, Hollenberg MD. Tyrosine kinase inhibitors and the contractile action of G protein-linked vascular agonists. Can J Physiol Pharmacol 1994; 72: 1075-1085.
42. Somlyo AV, Somlyo AP. Electromechanical and pharmacomechanical coupling in vascular smooth muscle. J Pharmacol Exp Ther 1968; 159: 129-145.
43. Hughes AD. Calcium channels in vascular smooth muscle cells. J Vasc Res 1995; 32: 353-370.
44. Ohya Y, Sperelakis N. Involvement of a GTP-binding protein in stimulating action of angiotensin II on calcium channels in vascular smooth muscle cells. Circ Res 1991; 68: 763-771.
45. 2+ in rat portal vein myocytes. J Biol Chem 1997; 272: 10095-10102.
46. Ishida M et al. Angiotensin II activates pp60c-src in vascular smooth muscle cells. Circ Res 1995; 77: 1053-1057.
47. Wijetunge S, Hughes AD. Activation of endogenous c-Src or a related tyrosine kinase by intracellular (pY)EEI peptide increases voltage-operated calcium channel currents in rabbit ear artery cells. FEBS Lett 1996; 399: 63-66.
48. Ruegg UT, Wallnofer A, Weir S, Cauvin C. Receptor-operated calcium-permeable channels in vascular smooth muscle. J Cardiovasc Pharmacol 1989; 14 (Suppl 6): S49-S58.
49. Bolton TB. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 1979; 59: 606-718.
50. Hughes AD, Bolton TB. Action of angiotensin II, 5-hydroxytryptamine and adenosine triphosphate on ionic currents in single ear artery cells of the rabbit. Br J Pharmacol 1995; 116: 2148-2154.
51. Wijetunge S, Hughes AD. Involvement of G proteins in agonist-induced opening of receptor operated channels in vascular smooth muscle cells. Br J Pharmacol 1994; 111: 265P(Abstr.).
52. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995; 268: C799-C822.
53. Kubo M, Quayle JM, Standen NB. Angiotensin II inhibition of ATP-sensitive K+ currents in rat arterial smooth muscle cells through protein kinase C. J Physiol Land 1997; 503: 489-496.
54. Miyoshi Y, Nakaya Y. Angiotensin II blocks ATP-sensitive K+ channels in porcine coronary artery smooth muscle cells. Biochem Biophys Res Commun 1991; 181: 700-706.
55. 2+-activated K+ channel by angiotensin II and endothelin-1. Biochem Pharmacol 1995; 49: 1051-1056.
56. Amedee T, Large WA, Wang Q. Characteristics of chloride currents activated by noradrenaline in rabbit ear artery cells. J Physiol Lond 1990; 428: 501-516.
57. White CR, Elton TS, Shoemaker RL, Brock TA. Calcium-sensitive chloride channels in vascular smooth muscle cells. Proc Soc Exp Biol Med 1995; 208: 255-262.
58. Jensen BL, Skott O. Blockade of chloride channels by DIDS stimulates renin release and inhibits contraction of afferent arterioles. Am J Physiol 1996; 270: F718-F727.
59. Carmines PK. Segment-specific effect of chloride channel blockade on rat renal arteriolar contractile responses to angiotensin II. Am J Hypertens 1995; 8: 90-94.
60. van KE et al. Alpha 1-adrenoreceptor blockade reduces the angiotensin II-induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery. Circ Res 1992; 70: 1122-1127.
61. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991; 68: 450-456.
62. deBlois D et al. Smooth muscle DNA replication in response to angiotensin II is regulated differently in the neointima and media at different times after balloon injury in the rat carotid artery. Role of AT1 receptor expression. Arterioscler Thromb Vasc Biol 1996; 16: 1130-1137.
63. van KE, Fingerle J, Daemen MJ. Angiotensin II-induced progression of neointimal thickening in the balloon-injured rat carotid artery is ATI receptor mediated. Arterioscler Thromb Vasc Biol 1996; 16: 857-863.
64. Holycross BJ, Peach MJ, Owens GK. Angiotensin II stimulates increased protein synthesis not increased DNA synthesis in intact rat aortic segments in vitro. J Vasc Res 1993; 30: 80-86.
65. Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988; 62: 749-756.
66. Leduc I, Haddad G, Giasson E, Meloche S. Involvement of a tyrosine kinase pathway in the growth promoting effects of angiotensin II on aortic smooth muscle cells. J Pharmacol Exp Ther 1995; 48: 582-592.
67. Schieffer B, Drexler H, Ling BN, Marrero MB. G protein-coupled receptors control vascular smooth muscle cell proliferation via pp60c-src and p21ras. Am J Physiol 1997; 272: C2019-C2030.
68. Herbert JM et al. Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro. Eur J Pharmacol 1997; 251: 143-150.
69. Campbell BM, Robertson ALJ. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol 1981; 35: 265-276.
70. Makita S, Nakamura M, Yoshida H, Hiramori K. Effect of angiotensin II receptor blocker on angiotensin II stimulated DNA synthesis of cultured human aortic smooth muscle cells. Life Sci 1995; 56: L383-L388.
71. Mii S, Ware JA, Mallette BA, Kent KC. Effect of angiotensin II on human vascular smooth muscle cell growth. J Surg Res 1994; 57: 174-178.
72. Patel MK et al. Effect of angiotensin II on the expression of the early growth response gene c-fos and DNA synthesis in human vascular smooth muscle cells. J Hypertens 1996; 14: 341-347.
73. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest 1992; 90: 456-461.
74. Koibuchi Y, Lee WS, Gibbons GH, Pratt RE. Role of transforming growth factor-beta 1 in the cellular growth response to angiotensin II. Hypertension 1993; 21: 1046-1050.
75. Schelling JR et al. Angiotensin II activates the beta 1 isoform of phospholipase C in vascular smooth muscle cells. Am J Physiol 1997; 272: C1558-C1566.
76. Marrero MB et al. The role of tyrosine phosphorylation in angiotensin II-mediated intracellular signalling. Cardiovasc Res 1995; 30: 530-536.
77. Clunn GF, Lymn JS, Schachter M, Hughes AD. Differential effects of lovastatin on mitogen induced calcium influx in human cultured vascular smooth muscle cells. Br J Pharmacol 1997; 121: 1789-1795.
78. Smith JB et al. Angiotensin II rapidly increases phosphatidate-phosphoinositide synthesis and phosphoinositide hydrolysis and mobilizes intracellular calcium in cultured arterial muscle cells. Proc Natl Acad Sci USA 1984; 81: 7812-7816.
79. Brock TA et al. Angiotensin increases cytosolic free calcium in cultured vascular smooth muscle cells. Hypertension 1985; 7: I105-I109.
80. Ford DA, Gross RW. Plasmenylethanolamine is the major storage depot for arachidonic acid in rabbit vascular smooth muscle and is rapidly hydrolyzed after angiotensin II stimulation. Proc Natl Acad Sci USA 1989; 86: 3479-3483.
81. Lassegue B et al. Phosphatidylcholine is a major source of phosphatidic acid and diacylglycerol in angiotensin II-stimulated vascular smooth-muscle cells, Biochem J 1933; 292: 509-517.
82. Freeman EJ, Tallant EA. Vascular smooth-muscle cells contain ATI angiotensin receptors coupled to phospholipase D activation. Biochem J 1994; 304: 543-548.
83. Suzuki A, Shinoda J, Oiso Y, Kozawa O. Tyrosine kinase is involved in angiotensin II-stimulated phospholipase D activation in aortic smooth muscle cells: function of Ca2+ influx. Atherosclerosis 1996; 121: 119-127.
84. Malarkey K et al. The role of protein kinase C in activation and termination of mitogen-activated protein kinase activity in angiotensin II-stimulated rat aortic smooth-muscle cells. Cell Signal 1996; 8: 123-129.
85. Langan EM et al. Regulation of MAP kinase activity by growth stimuli in vascular smooth muscle. J Surg Res 1994; 57: 215-220.
86. Liao DF, Monia B, Dean N, Berk BC. Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells. J Biol Chem 1997; 272: 6146-6150.
87. Liao DF et al. Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells, Role of Raf. Circ Res 1996; 79: 1007-1014.
88. Marrero MB et al. Angiotensin II signalling events mediated by tyrosine phosphorylation. Cell Signal 1996; 8: 21-26.
89. Tsuda T et al. Vasoconstrictor-induced protein-tyrosine phosphorylation in cultured vascular smooth muscle cells. FEBS Lett 1991; 285: 44-48.
90. Butcher RD, Schollmann C, Marme D. Angiotensin II mediates intracellular signalling in vascular smooth muscle cells by activation of tyrosine-specific protein kinases and c-raf-1. Biochem Biophys Res Commun 1993; 196: 1280-1287.
91. Turner CE, Pietras KM, Taylor DS, Molloy CJ. Angiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells. J Cell Sci 1995; 108: 333-342.
92. Leduc I, Meloche S. Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells. J Biol Chem 1995; 270: 4401-4404.
93. Marrero MB et al. Electroporation of pp60c-src antibodies inhibits the angiotensin II activation of phospholipase C-gamma 1 in rat aortic smooth muscle cells. J Biol Chem 1995; 270: 15734-15738.
94. 2+ transients are not required for platelet-derived growth factor to induced cell cycle progression of vascular smooth muscle cells in primary culture. J Biol Chem 1994; 269: 9011-9018.
95. Sadoshima J-I, Izumo S. The heterotrimeric Gq protein-coupled angiotensin II receptor activates p21ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J 1996; 15: 775-787.
96. Saward I, Zahradka P. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res 1997; 81: 249-257.
97. Huckle WR, Dy RC, Earp HS. Calcium-dependent increase in tyrosine kinase activity stimulated by angiotensin II. Proc Natl Acad Sci USA 1992; 89: 8837-8841.
98. 2+/calmodulin-sensitive tyrosine kinase. J Biol Chem 1996; 271: 14169-14175.
99. Marrero MB et al. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 1995; 375: 247-250.